A retrospective analysis from European Radiology quantitatively evaluated lung parenchyma and airway wall enhancement by using a monophasic contrast-enhanced spectral detector CT acquisition in individuals with healthy lungs. Spectral CT demonstrated to be effective in quantifying lung parenchyma and airway wall enhancement with a single contrast phase acquisition. The results achieved with this imaging approach may potentially be extended to characterizing inflammatory airway diseases.